Leading allergy medical societies and patient advocacy groups highlight path forward to advance food allergy prevention, treatment, and managementWashington, DC, March 19, 2026 (GLOBE NEWSWIRE) -- The ...

ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer EURneffy-t ...

Dupilumab yields larger improvements in lung function than several other biologics in patients with severe asthma.

Glaxo Smith Kline’s decision to discontinue a popular children’s asthma inhaler, Flovent, more than two years ago has caused ...

CEO Barry Quart outlined the company’s focus on rademikibart, an IL-4 receptor alpha monoclonal antibody he described as a “next-generation DUPIXENT,” during a presentation at the Leerink Partners ...

Use of single maintenance and reliever therapy (SMART) for moderate-to-severe asthma saved money by improving outcomes, according to a meta-analysis. While SMART is recommended by guidelines, ...

Arjun Mohan received funding from Verona Pharm LLC and Regeneron Pharm for Consulting Services (one time, relationship has ended). These services have no conflict with the article written here ...

Asthma is a chronic lung disease that causes the airways to become inflamed and narrowed. Symptoms like coughing, dyspnea (shortness of breath), wheezing, and chest tightness can range from mild to ...

Asthma care continues to develop, particularly in how treatment and long-term management are approached. This article outlines current treatment and management recommendations for patients aged 12 and ...